You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
溢多利(300381.SZ)擬出售醫藥板塊業務 或構成重大資產重組
格隆匯 10-20 17:17

格隆匯10月20日丨溢多利(300381.SZ)公佈,公司是專業生物技術企業,聚焦於生物醫藥和生物農牧領域,從事生物酶製劑、甾體激素原料藥、植物提取物、動物營養與健康等產品的研發、生產、銷售和服務,並向客户提供整體生物技術解決方案。基於公司業務發展及戰略佈局考慮,公司擬出售醫藥板塊業務。該次交易可能將構成重大資產重組。

2021年10月20日,公司與常德財鑫金融控股集團有限責任公司、津市嘉山產業發展投資有限公司就該次交易簽署了意向協議,該次交易尚處於籌劃階段,交易方案尚需進一步商討論證,並需按照相關法律法規的規定履行各方必要的內外部相關決策、審批程序,存在未能通過該等決策、審批程序的風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account